LXRX 250117 7.50C (LXRX250117C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

LXRX250117C7500

Watchlist

0.04
0.000.00%

15min DelayClose Dec 24 13:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Comments

Jaguar8

Dec 22 12:36

NEWS FRIDAY 12/20

$Lexicon Pharmaceuticals (LXRX.US)$
Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
Lexicon Pharmaceuticals (LXRX) has received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application for Zynquista™ (sotagliflozin). The drug was intended as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease (CKD). This decision was anticipated, aligning with Lexicon's previous s...

james beets

Dec 20 15:10

$Lexicon Pharmaceuticals (LXRX.US)$
come on fdaaaaaaaaaa

905745367

Dec 20 12:53

$Lexicon Pharmaceuticals (LXRX.US)$ go go

SkinnyChick

Dec 19 23:42

$Lexicon Pharmaceuticals (LXRX.US)$ let see if it will still run after release of good news. Investors losing confidence.

Trytosaveabit

Dec 19 19:05

Just a heads up!

$Lexicon Pharmaceuticals (LXRX.US)$ Tomorrow they get a second at bat for FDA approval! Last go round they were issued a CRL! Well here we are quite a ways removed from that first PDUFA calendar date! IMO since this is a redo. Hehehe! IMO that does make a ( NORMALLY ) bit better odds of a approval! But in this case at the pre meeting it didn’t look very positive! Also the answer can come anytime between tomorrow/Friday all the way to Monday!